Lower Biological Age Linked to Reduced Stroke Risk & Brain Damage

The difference between your body’s biological age and your chronological age – the number of years you’ve lived – may play a significant role in long-term brain health, according to preliminary research presented this week. A study unveiled March 5, 2026, and slated for full presentation at the American Academy of Neurology’s (AAN) 78^th Annual Meeting in April, suggests that narrowing the gap between these two ages is linked to a lower risk of stroke and fewer signs of brain damage.

Researchers emphasize that this study demonstrates an association, not a direct cause-and-effect relationship. Though, the findings offer a compelling avenue for exploration, suggesting that lifestyle factors influencing biological age could potentially be harnessed to protect cognitive function as we age.

Understanding Biological vs. Chronological Age

Chronological age is simply the time elapsed since birth. Biological age, however, is a more complex measure reflecting the actual state of your cells and organs. It’s influenced by a multitude of factors, including genetics, diet, exercise, sleep, and exposure to environmental toxins. Essentially, biological age reflects how well your body is functioning compared to others of the same chronological age.

The study, led by Cyprien Rivier, MD, MSc, of Yale University and a member of the AAN, analyzed data from a large healthcare research database encompassing 258,169 individuals. Researchers assessed biological age by measuring 18 biomarkers in blood samples – including cholesterol levels, red blood cell volume, and white blood cell counts – both at the beginning of the study and again six years later for a subset of participants. Participants were then followed for an average of 10 years to track stroke incidence. A portion of the study group also underwent cognitive testing and brain scans to evaluate brain health.

Key Findings: The Age Gap and Brain Health

At the study’s outset, participants had an average biological age of 54, despite a chronological age of 56. After six years, their average biological age had increased to 58, while their chronological age reached 62. This illustrates that, on average, participants’ bodies were aging at a slightly slower rate than their calendar age.

The research revealed a concerning trend: individuals whose biological age exceeded their chronological age exhibited less favorable brain scan results and performed worse on cognitive tests. Critically, they also faced a 41% higher risk of stroke. Conversely, those who successfully narrowed the gap between their biological and chronological ages experienced a 23% reduction in stroke risk during the follow-up period.

Further analysis of brain scans showed that those who improved their biological age gap also had lower volumes of white matter hyperintensities – a marker of damage to white matter tissue, which is crucial for efficient communication between different brain regions. Specifically, for each standard deviation of improvement in the age gap, participants experienced a 13% reduction in the total volume of this brain damage.

What Influences the Biological Age Gap?

While the study didn’t directly investigate the factors driving changes in the biological age gap, Dr. Rivier suggests that lifestyle habits known to support cardiovascular and metabolic health likely play a key role. These include adopting a healthy diet, engaging in regular physical exercise, prioritizing adequate sleep, and maintaining healthy blood pressure. The American Academy of Neurology highlights the importance of these factors in overall brain health.

It’s significant to note that the study accounted for other factors that could influence stroke risk and brain damage, such as pre-existing high blood pressure, vascular conditions, and socioeconomic status. This strengthens the association observed between the biological age gap and brain health outcomes.

Limitations and Future Research

The researchers acknowledge several limitations. The study’s design does not allow for definitive conclusions about cause and effect. While an association was observed, it’s possible that other unmeasured factors contributed to the observed differences. Repeat blood tests were only available for a subset of participants, limiting the ability to draw firm conclusions about changes over time, particularly in relation to cognitive performance.

“More research is needed, testing whether lowering people’s biological age gap can be demonstrated to reduce the risk of stroke and later-life brain injury,” Dr. Rivier stated. Future studies could explore the effectiveness of targeted interventions – such as lifestyle programs or pharmacological approaches – aimed at reducing biological age and improving brain health.

The Role of Biomarkers and Precision Medicine

The study’s use of 18 biomarkers to assess biological age represents a step towards more personalized approaches to healthcare. Traditionally, medical assessments have relied heavily on chronological age as a primary indicator of risk. However, recognizing that individuals age at different rates – and that biological age is a more accurate reflection of health status – opens the door to tailored interventions. News Medical details the study’s methodology and findings.

What Which means for You

This research doesn’t mean you can “turn back the clock” entirely. However, it reinforces the importance of prioritizing lifestyle factors known to promote overall health and well-being. Focusing on a heart-healthy diet, regular exercise, sufficient sleep, and effective stress management may contribute to a more favorable biological age and potentially reduce your risk of stroke and cognitive decline. It’s crucial to discuss any concerns about your health with a qualified healthcare professional.

Looking Ahead: Ongoing Research and Clinical Trials

The findings from this study are expected to stimulate further research into the mechanisms underlying biological aging and the potential for interventions to modify it. The AAN Annual Meeting, taking place April 18-22, 2026, in Chicago, IL, will feature presentations on a wide range of neurological research, including studies exploring novel approaches to prevent and treat brain disorders. The American Academy of Neurology website provides details about the meeting and its program.

AEON Biopharma also presented research at the AAN meeting, though unrelated to this study, highlighting the ongoing focus on neurological advancements. Business Insider reported on AEON’s presentation regarding a biosimilar to Botox.